Skip to main content


  • Organization
    US Department of Energy

  • Use Statement - Please enter your reason for creating an NCI Hub account.
    (not set)

  • Employment Status
    (not set)

  • Website
    (not set)

  • Telephone

  • Reason
    Keeping current in subject matter

  • Biography
    Christopher Miller is currently a AAAS Science and Technology Policy Fellow at the U.S. Department of Energy, Office of Science, Advanced Scientific Computing Research. He received his Sc.B. in Cell and Molecular Biology from Brown University. He earned the M.D. degree from the Carver College of Medicine at the University of Iowa and completed internship training in Internal Medicine at University Hospitals Case Medical Center in Cleveland, OH. He completed a postdoctoral research fellowship in Sleep Medicine, Neurobiology and Epidemiology at Case Western Reserve University, where he investigated the application of entropy analysis algorithms to physiological time-series data to inform predictive modeling of clinical outcomes in patients with respiratory disorders and sleep disordered breathing. He also completed a postdoctoral fellowship in Clinical Medical Informatics at the N.I.H. Lister Hill National Center for Biomedical Communication at the National Library of Medicine where he used natural language processing and semantic predication extraction to visualize and analyze conceptual relationships in Medline text to facilitate literature-based discovery and hypothesis generation. Dr. Miller has biomedical research experience in Immunology and Molecular Virology. He has also worked as a Medical Informatics Consultant at Deloitte Consulting and was involved in the development of the planned integrated electronic medical record system for the Veterans Administration and Department of Defense. Dr. Miller also worked as Senior Bioinformatics Scientist at Inova Translational Medicine Institute, a private research institute affiliated with Inova Health System in Northern Virginia, using Genomics to help realize the promise of Personalized Medicine, where he helped develop a pharmacogenomics panel which uses a patient’s genome to assess potential efficacy and risk of adverse events before a drug is prescribed.